1178139

Khaled Tawansy, MD — FEI 3023061364

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 24, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Los Angeles, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance